HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James E Tcheng Selected Research

Abciximab (ReoPro)

7/2009Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial.
8/2006Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
6/2006Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial.
2/2006Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.
8/2005Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.
5/2005Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.
4/2005Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
4/2005Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
2/2005Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction.
1/2005Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James E Tcheng Research Topics

Disease

52Myocardial Infarction
04/2012 - 01/2002
19Hemorrhage
04/2012 - 09/2002
11Acute Coronary Syndrome
01/2019 - 09/2002
9Cardiovascular Diseases (Cardiovascular Disease)
07/2015 - 07/2002
9Infarction (Infarctions)
12/2008 - 03/2002
8ST Elevation Myocardial Infarction
01/2019 - 04/2005
8Thrombosis (Thrombus)
02/2010 - 08/2002
7Stroke (Strokes)
04/2012 - 03/2002
6Ischemia
06/2013 - 03/2002
5Unstable Angina
02/2008 - 08/2002
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 08/2003
4Thrombocytopenia (Thrombopenia)
11/2007 - 01/2003
4Diabetes Mellitus
08/2005 - 09/2002
3Heart Failure
01/2018 - 08/2003
3Non-ST Elevated Myocardial Infarction
11/2007 - 08/2006
2Hypertension (High Blood Pressure)
01/2006 - 09/2002
2Anemia
08/2004 - 07/2004
2Renal Insufficiency (Renal Failure)
07/2004 - 12/2003
1Intermittent Claudication
01/2021
1Chronic Limb-Threatening Ischemia
01/2021
1Disease Susceptibility (Diathesis)
04/2016
1Neoplasms (Cancer)
07/2015
1Ventricular Tachycardia
03/2012
1Ventricular Fibrillation
03/2012
1Coronary Disease (Coronary Heart Disease)
02/2008
1Coronary Thrombosis
02/2008
1Leukocytosis (Pleocytosis)
04/2007
1Atherosclerosis
11/2006
1Peripheral Arterial Disease
10/2006
1Chest Pain (Chest Pains)
08/2006
1Obesity
01/2006
1Hyperlipidemias (Hyperlipidemia)
01/2006
1Shock
08/2005
1Pathologic Constriction (Stenosis)
07/2005
1Mitral Valve Insufficiency (Mitral Regurgitation)
04/2004
1Chronic Renal Insufficiency
01/2003
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2003

Drug/Important Bio-Agent (IBA)

26Abciximab (ReoPro)FDA Link
07/2009 - 03/2002
11Eptifibatide (Integrilin)FDA Link
02/2010 - 08/2002
8Glycoproteins (Glycoprotein)IBA
01/2007 - 02/2003
7Platelet Membrane Glycoprotein IIbIBA
10/2006 - 08/2002
6Platelet Membrane GlycoproteinsIBA
02/2010 - 09/2002
6Heparin (Liquaemin)FDA LinkGeneric
01/2007 - 09/2002
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2009 - 08/2002
4Clopidogrel (Plavix)FDA Link
04/2012 - 11/2007
4omega-Chloroacetophenone (Mace)IBA
02/2009 - 04/2004
4EsapentIBA
11/2004 - 01/2002
2Pharmaceutical PreparationsIBA
04/2016 - 09/2002
2Prasugrel HydrochlorideFDA Link
04/2012 - 11/2009
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2009 - 11/2007
2thienopyridineIBA
11/2009 - 08/2009
2MB Form Creatine KinaseIBA
09/2003 - 01/2002
1Rosuvastatin Calcium (Crestor)FDA Link
01/2016
1iodixanol (Visipaque)FDA Link
01/2016
1candesartanIBA
01/2016
1Contrast MediaIBA
01/2016
1Iopamidol (Isovue)FDA LinkGeneric
01/2016
1IceIBA
02/2010
1S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA
02/2010
1Ticlopidine (Ticlid)FDA LinkGeneric
12/2008
14- ethyl- 6- oxa- 1- azatricyclo(4.2.2.0)dodecan- 5- one (AF 3)IBA
02/2008
1paragonIBA
02/2008
1AnticoagulantsIBA
11/2007
1Enoxaparin (Lovenox)FDA LinkGeneric
11/2007
1Indicators and Reagents (Reagents)IBA
11/2006
1bivalirudin (Angiomax)FDA Link
10/2006
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2006
1CreatinineIBA
01/2006
1Insulin (Novolin)FDA Link
08/2005
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2005
1N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA
07/2005
1Biological ProductsIBA
09/2004
1EnzymesIBA
09/2003
1Tirofiban (Aggrastat)FDA Link
09/2002
1tranilastIBA
09/2002
1N(2)-(3-trifluoromethylphenyl)guanineIBA
01/2002

Therapy/Procedure

46Percutaneous Coronary Intervention
01/2019 - 08/2002
20Therapeutics
01/2018 - 03/2002
14Stents
01/2019 - 01/2002
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2013 - 09/2002
3Thrombolytic Therapy
03/2006 - 03/2002
2Blood Transfusion (Blood Transfusions)
07/2009 - 08/2005
2Treatment Delay
06/2006 - 09/2004
1Vascular Surgical Procedures
01/2021
1Patient Readmission
01/2016
1Intravenous Administration
02/2010
1Drug Therapy (Chemotherapy)
11/2007
1Length of Stay
08/2005